Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063841 · ClinicalTrials.gov registry record · Early Phase 1
Digestive Endoscopy Suite Radiation Controlling Protective Strategies
A Early Phase 1 study of Radiation Exposure, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT02063841 is a Early Phase 1 study of Radiation Exposure that has completed, run by Yale University. The registered enrollment target is 2 participants, below the 50-participant average among 7 other Radiation Exposure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02063841, a Early Phase 1 study of Radiation Exposure, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
ERCP is associated with radiation exposure to the endoscopist and staff, which may be significant at high volume programs despite the use of lead aprons. We hypothesize that draping of the fluoroscopy image intensifier may significantly reduce staff radiation exposure and help achieve implementation of the ALARA (As Low As Reasonably Achievable) principle.
Conditions Studied
Interventions
- DEVICE lead-free protective drape containing bismuth and antimony (RADPAD®)
- DEVICE sterile identical sham drape
Study Locations (1)
Connecticut
- Endoscopy Center, Smilow Cancer Center, Yale New Haven Hospital - New Have
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-08 |
| Est. Completion | 2013-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02063841
The ClinicalTrials.gov registry entry for NCT02063841 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 50-participant average among 7 other Radiation Exposure trials with a reported enrollment target (96% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Exposure appearing as the primary indexed condition, and to 2 interventions - of which lead-free protective drape containing bismuth and antimony (RADPAD®) is the first listed.
NCT02063841 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02063841 about?
NCT02063841 is a clinical study titled "Digestive Endoscopy Suite Radiation Controlling Protective Strategies". ERCP is associated with radiation exposure to the endoscopist and staff, which may be significant at high volume programs despite the use of lead aprons. We hypothesize that draping of the fluoroscopy image intensifier may significantly reduce staff radiation exposure and help achieve implementation...
What is the current status of trial NCT02063841?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2013-08. Estimated completion is 2013-11.
What conditions does trial NCT02063841 study?
This clinical trial studies the following conditions: Radiation Exposure.
What interventions are being tested in trial NCT02063841?
The interventions under investigation include: lead-free protective drape containing bismuth and antimony (RADPAD®) (DEVICE), sterile identical sham drape (DEVICE).
Who is sponsoring clinical trial NCT02063841?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02063841 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
RECRUITING · NA
-
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
RECRUITING
-
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
RECRUITING · NA
-
Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Reduce Radiation Exposure in Fluoroscopic Interventions Evaluation
COMPLETED · NA
-
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.